|
RAB5A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.765200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.816700E-03 |
| Normal-vs-Stage2 |
5.318000E-03 |
| Normal-vs-Stage3 |
1.56438999999731E-05 |
| Normal-vs-Stage4 |
4.030200E-04 |
| Stage1-vs-Stage2 |
5.344000E-01 |
| Stage1-vs-Stage3 |
2.082400E-02 |
| Stage1-vs-Stage4 |
1.318960E-01 |
| Stage2-vs-Stage3 |
3.073400E-01 |
| Stage2-vs-Stage4 |
4.909800E-01 |
| Stage3-vs-Stage4 |
8.323400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.32659999999107E-05 |
| Normal-vs-AfricanAmerican |
4.823800E-01 |
| Normal-vs-Asian |
1.562100E-02 |
| Caucasian-vs-AfricanAmerican |
3.576500E-02 |
| Caucasian-vs-Asian |
3.263600E-01 |
| AfricanAmerican-vs-Asian |
2.648200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.383530E-03 |
| Normal-vs-Female |
3.406400E-04 |
| Male-vs-Female |
7.965800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.378090E-02 |
| Normal-vs-Age(41-60Yrs) |
7.53180000000464E-05 |
| Normal-vs-Age(61-80Yrs) |
7.91490000000561E-05 |
| Normal-vs-Age(81-100Yrs) |
9.205800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.520100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.758000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.837200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.213400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.375000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.613200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.618950E-01 |
| Classical-VS-Follicular |
6.844600E-01 |
| Classical-VS-Other |
5.673800E-01 |
| Classical-VS-Normal |
1.144700E-03 |
| Tall-VS-Follicular |
1.017020E-01 |
| Tall-VS-Other |
8.596400E-01 |
| Tall-VS-Normal |
6.157600E-04 |
| Follicular-VS-Other |
2.669200E-01 |
| Follicular-VS-Normal |
3.363700E-02 |
| Other-VS-Normal |
6.488400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.833700E-04 |
| Normal-vs-N1 |
2.215600E-03 |
| N0-vs-N1 |
8.147200E-01 |
|
|
